Health minister says 921 H1N1 cases in Yemen.
The minister reviewed developments related to the swine flu virus since registration of first case in Yemen for a student came from United Stated.
He called on citizens to follow up protective measures from virus
The first death from the disease reported on 19th August.
Last week, the Yemeni pharmaceutical company YEDCO has developed anti-viral drug for the Swine Flue (H1N1) and registered it at the Yemeni General Authority of Medicines and Medical Supplements.
General Director of the High Authority for Medicines and Medical Supplements Dr. Abdul-Monem al-Hakami said that the drug registered by YEDCO at the authority is the same medicine invented by a Switzerland company before years.
Speaking to Saba, al-Hakami added that the Switzerland medicine called "Tamiflu", which consists of Oseltaamivir phosphate75mg capsules, is anti-viral drug for the seasonal flue that approved recently by WHO as anti-viral drug for curing Swine Flue and Bird Flue and now being produced by a number of companies in the world.
Sabanews.net 1999 - 2009
Provided by Syndigate.info an Albawaba.com company
|Printer friendly Cite/link Email Feedback|
|Publication:||Yemen News Agency (SABA)|
|Date:||Oct 12, 2009|
|Previous Article:||Kuwaiti national gets 25-year imprisonment in Yemen.|
|Next Article:||Yemen, WB discuss evaluation of health sector reform project.|